Precision Biologics, Inc. to present at SITC 2026, Phoenix, AZ, November 7, 2026
Precision Biologics, Inc. will present during the scientific poster session at the Society for Immunotherapy of Cancer Annual Meeting 2026.
The title of the poster is: “In vivo efficacy of the antibody-drug conjugate (ADC) PB-vcMMAE-5 in an ovarian cancer patient-derived xenograft (PDX) model expressing truncated core 2 O-glycans” and it will be presented on Saturday, November 7th, 12:30pm – 1:30pm – Day 2 of SITC 2026, (Society for Immunotherapy of Cancer 41st Annual Meeting), at the Phoenix Convention Center – North Building, Lower Level – Exhibition Halls 4 – 6, in Poster session primary category: Immuno-Conjugates and Chimeric Molecules, Poster no. #888.